Correlation Between Caribou Biosciences and Allogene Therapeutics
Can any of the company-specific risk be diversified away by investing in both Caribou Biosciences and Allogene Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Caribou Biosciences and Allogene Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Caribou Biosciences and Allogene Therapeutics, you can compare the effects of market volatilities on Caribou Biosciences and Allogene Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Caribou Biosciences with a short position of Allogene Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Caribou Biosciences and Allogene Therapeutics.
Diversification Opportunities for Caribou Biosciences and Allogene Therapeutics
0.79 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Caribou and Allogene is 0.79. Overlapping area represents the amount of risk that can be diversified away by holding Caribou Biosciences and Allogene Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Allogene Therapeutics and Caribou Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Caribou Biosciences are associated (or correlated) with Allogene Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Allogene Therapeutics has no effect on the direction of Caribou Biosciences i.e., Caribou Biosciences and Allogene Therapeutics go up and down completely randomly.
Pair Corralation between Caribou Biosciences and Allogene Therapeutics
Given the investment horizon of 90 days Caribou Biosciences is expected to under-perform the Allogene Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Caribou Biosciences is 1.18 times less risky than Allogene Therapeutics. The stock trades about -0.2 of its potential returns per unit of risk. The Allogene Therapeutics is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest 184.00 in Allogene Therapeutics on October 20, 2024 and sell it today you would lose (2.00) from holding Allogene Therapeutics or give up 1.09% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Caribou Biosciences vs. Allogene Therapeutics
Performance |
| Timeline |
| Caribou Biosciences |
| Allogene Therapeutics |
Caribou Biosciences and Allogene Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Caribou Biosciences and Allogene Therapeutics
The main advantage of trading using opposite Caribou Biosciences and Allogene Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Caribou Biosciences position performs unexpectedly, Allogene Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Allogene Therapeutics will offset losses from the drop in Allogene Therapeutics' long position.| Caribou Biosciences vs. Intellia Therapeutics | Caribou Biosciences vs. Editas Medicine | Caribou Biosciences vs. Crispr Therapeutics AG | Caribou Biosciences vs. Verve Therapeutics |
| Allogene Therapeutics vs. Heron Therapeuti | Allogene Therapeutics vs. Annexon | Allogene Therapeutics vs. Sangamo Therapeutics | Allogene Therapeutics vs. Beam Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Other Complementary Tools
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |